About personalis inc. - PSNL
Personalis, Inc. engages in the provision of advanced genomic tests for cancer. The firm is also involved in providing sequencing and data analysis services to support population sequencing initiatives. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in February 2011 and is headquartered in Fremont, CA.
PSNL At a Glance
Personalis, Inc.
6600 Dumbarton Circle
Fremont, California 94555
| Phone | 1-650-752-1300 | Revenue | 84.61M | |
| Industry | Medical/Nursing Services | Net Income | -81,284,000.00 | |
| Sector | Health Services | 2024 Sales Growth | 15.151% | |
| Fiscal Year-end | 12 / 2025 | Employees | 229 | |
| View SEC Filings |
PSNL Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 4.047 |
| Price to Book Ratio | 2.426 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -3.52 |
| Enterprise Value to Sales | 2.385 |
| Total Debt to Enterprise Value | 0.22 |
PSNL Efficiency
| Revenue/Employee | 369,493.45 |
| Income Per Employee | -354,951.965 |
| Receivables Turnover | 10.395 |
| Total Asset Turnover | 0.342 |
PSNL Liquidity
| Current Ratio | 6.459 |
| Quick Ratio | 6.332 |
| Cash Ratio | 5.944 |
PSNL Profitability
| Gross Margin | 31.703 |
| Operating Margin | -80.681 |
| Pretax Margin | -96.043 |
| Net Margin | -96.064 |
| Return on Assets | -32.818 |
| Return on Equity | -48.908 |
| Return on Total Capital | -32.868 |
| Return on Invested Capital | -39.949 |
PSNL Capital Structure
| Total Debt to Total Equity | 21.852 |
| Total Debt to Total Capital | 17.933 |
| Total Debt to Total Assets | 16.41 |
| Long-Term Debt to Equity | 17.238 |
| Long-Term Debt to Total Capital | 14.146 |